Title:
NUTRITIONAL SUPPLEMENTS AFFECTING CARDIOVASCULAR EFFICIENCY
Document Type and Number:
WIPO Patent Application WO/2018/064966
Kind Code:
A1
Abstract:
Nutritional supplement compositions for improving cardiovascular efficiency are disclosed. A nutritional supplement composition can include astaxanthin derived from Haematococcus pluvialis Extract blended with carrier oils and antioxidants. Related processes are also disclosed.
Inventors:
LI YANMEI (CN)
DING LIXIN (CN)
DING LIXIN (CN)
Application Number:
PCT/CN2017/104837
Publication Date:
April 12, 2018
Filing Date:
September 30, 2017
Export Citation:
Assignee:
BEIJING GINGKO GROUP BIOLOGICAL TECH CO LTD (CN)
International Classes:
A61K36/02; A61K9/48; A61P9/00
Foreign References:
| CN104643100A | 2015-05-27 | |||
| CN101053409A | 2007-10-17 | |||
| CN105582001A | 2016-05-18 | |||
| CN101023963A | 2007-08-29 | |||
| CN104351807A | 2015-02-18 | |||
| JP2014520165A | 2014-08-21 | |||
| JP2011063547A | 2011-03-31 | |||
| JP2011063547A | 2011-03-31 |
Other References:
EARNEST C.P. ET AL.: "Effect of Astaxanthin on Cycling Time Trial Performance", INT. J. SPORTS MED., vol. 32, no. 11, 1 October 2011 (2011-10-01), pages 882 - 888, XP055596983, ISSN: 0172-4622, DOI: 10.1055/s-0031-1280779
C.P. EARNEST ET AL.: "Effect of Astaxanthin on Cycling Time Trial Performance", INTERNATIONAL JOURNAL OF SPORTS MEDICINE, vol. 32, no. 11, 1 November 2011 (2011-11-01), pages 882 - 888, XP055596983, DOI: 10.1055/s-0031-1280779
ROBERT G. FASSETT ET AL.: "Astaxanthin in Cardiovascular Health and Disease", MOLECULES, vol. 17, no. 2, 20 February 2012 (2012-02-20), pages 2030 - 2048, XP055670425, DOI: 10.3390/molecules17022030
C.P. EARNEST ET AL.: "Effect of Astaxanthin on Cycling Time Trial Performance", INTERNATIONAL JOURNAL OF SPORTS MEDICINE, vol. 32, no. 11, 1 November 2011 (2011-11-01), pages 882 - 888, XP055596983, DOI: 10.1055/s-0031-1280779
ROBERT G. FASSETT ET AL.: "Astaxanthin in Cardiovascular Health and Disease", MOLECULES, vol. 17, no. 2, 20 February 2012 (2012-02-20), pages 2030 - 2048, XP055670425, DOI: 10.3390/molecules17022030
Attorney, Agent or Firm:
KANGXIN PARTNERS, P.C. (CN)
Download PDF: